Cigna’s first-quarter report shows strong numbers, but Barclays warns the road ahead could get rocky. Barclays highlights ...

Citi analysts reiterated a Buy rating on Gilead Sciences, Inc. (NASDAQ:GILD) stock and maintained a $125 price target. The ...

Ratings for CVS Health CVS were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish ...

The Cigna Group CI, a longstanding global health company, continues to offer a variety of health solutions and insurance ...

Citi initiated coverage of Aspen Insurance Holdings (AHL) with a Buy rating on Monday based on the insurer's recently ...